Lupin share jumps 3% on launching anesthesia injection in US

Lupin share jumps 3% on launching anesthesia injection in US

  Shares of Lupin Ltd rose 3% on 8 november  after the company announced the launch of Rocuronium Bromide injection, an anesthesia medicine, in the United States.  The launch came after Lupin’s alliance partner Caplin Steriles received approval from the United States Food and Drug Administration (USFDA), the global pharma major said in a filing … Read more

Lupin Receives Tentative USFDA Approval for Tolvaptan Tablets; Shares Gain

Lupin Receives Tentative USFDA Approval for Tolvaptan Tablets; Shares Gain

Lupin shares opened 1% above on 6 October after the company announced receiving tentative approval from USFDA ( the United States Food and Drug Administration). JOIN OUR TELEGRAM The drug company has received interim approval from the USFDA for tolvaptan 15 mg, 30 mg, 45 mg, 60 mg, and 90 mg tablets. This drug is … Read more